← Back to the drill

Where these questions come from

Every question is written against the published competency blueprint for tobacco-treatment-specialist certification, and checked by a program before it reaches the drill. This page shows exactly what that means, and what it does not.

What the checking actually proves

The primary literature

Freely readable. Every link below was checked to resolve, and its title confirmed, when this page was built.

Provenance, question by question

Every question in the bank, what it claims, and how far it has been checked.

Competency 1 · Tobacco Dependence Knowledge and Education

14% of the exam · 43 questions · 31 carry a source-matched claim

Show all 43

ID	Topic	Claim	Review
C01-001	Tobacco use disparities by population	source-matched	reviewed
C01-002	Tobacco use disparities by population	source-matched	reviewed
C01-003	Youth tobacco use prevalence (2022)	source-matched	reviewed
C01-004	Age of onset of tobacco use	source-matched	reviewed
C01-005	Tobacco use as a chronic process	source-matched	reviewed
C01-007	WHO global mortality burden — fraction of premature deaths	source-matched	reviewed
C01-008	WHO global mortality burden — annual deaths worldwide	source-matched	reviewed
C01-009	WHO global mortality burden — secondhand smoke deaths	source-matched	reviewed
C01-010	Nicotine neuropharmacology	source-matched	reviewed
C01-011	Nicotine as primary addictive chemical across product types	source-matched	reviewed
C01-012	Life expectancy benefit of quitting	source-matched	reviewed
C01-013	Morbidity benefit of quitting, beyond added years	source-matched	reviewed
C01-014	2014 Surgeon General Report 50th-anniversary update	source-matched	reviewed
C01-015	2014 Surgeon General Report — publication year	source-matched	reviewed
C01-016	Smoker mortality multiplier	source-matched	reviewed
C01-017	Smoking-attributable lung cancer deaths	source-matched	reviewed
C01-018	Smoking-attributable heart disease deaths	source-matched	reviewed
C01-019	Smoking-attributable COPD deaths	source-matched	reviewed
C01-020	Smokeless tobacco cardiovascular risk	source-matched	reviewed
C01-021	Smokeless tobacco carcinogen count	source-matched	reviewed
C01-022	What the treatment evidence rests on	source-matched	reviewed
C01-023	Identifying tobacco use status at every encounter	source-matched	reviewed
C01-024	Effective treatment delivery modalities	source-matched	reviewed
C01-025	Why counselling plus medication beats either alone	source-matched	reviewed
C01-026	Alternative modalities — evidence level	source-matched	reviewed
C01-027	2020 SGR — persistence of disparities	source-matched	reviewed
C01-028	Do population-level control programs work	source-matched	reviewed
C01-029	Barriers to offering tobacco treatment — time constraints	source-matched	reviewed
C01-030	Barriers to offering tobacco treatment — personal tobacco use	source-matched	reviewed
C01-031	The 5 A's framework	source-matched	reviewed
C01-032	Other abbreviated brief-intervention models	source-matched	reviewed
C01-033	Describing prevalence patterns across subgroups	skill	reviewed
C01-035	Role of treatment within a tobacco control program	skill	reviewed
C01-036	Using national reports and guidelines to inform practice	skill	reviewed
C01-037	What drives uptake beyond the individual	skill	reviewed
C01-038	Explaining mechanisms of tobacco-induced disorders	skill	reviewed
C01-039	Causes of tobacco dependence	skill	reviewed
C01-040	Deciding whether a client meets the criteria	skill	reviewed
C01-041	Chronic relapsing nature of dependence	skill	reviewed
C01-042	Culturally and age-appropriate patient education	skill	reviewed
C01-043	Comparing evidence-based strategies	skill	reviewed
C01-044	Discussing alternative therapies with a patient	skill	reviewed
C01-045	Accessing current information on tobacco topics	skill	reviewed

Competency 2 · Counseling Skills

17% of the exam · 51 questions · 42 carry a source-matched claim

Show all 51

ID	Topic	Claim	Review
C02-001	Counseling modality effectiveness	source-matched	reviewed
C02-002	Behavioral counseling delivery sources	source-matched	reviewed
C02-003	Combined counseling and pharmacotherapy intensity	source-matched	reviewed
C02-004	Quitline referral cost-effectiveness	source-matched	reviewed
C02-005	Proactive quitline referral design	source-matched	reviewed
C02-006	Reactive counseling definition	source-matched	reviewed
C02-007	Proactive counseling definition	source-matched	reviewed
C02-008	Client-Centered Therapy: client as expert	source-matched	reviewed
C02-009	Client-Centered Therapy: partners in the treatment plan	source-matched	reviewed
C02-010	Client-Centered Therapy: flexibility to readiness stage	source-matched	reviewed
C02-011	Client-Centered Therapy: strongest evidence for ambivalent clients	source-matched	reviewed
C02-012	Motivational Interviewing: purpose and ambivalence	source-matched	reviewed
C02-013	Motivational Interviewing: equal partnership	source-matched	reviewed
C02-014	Advice conditioned on client permission	source-matched	reviewed
C02-015	Empathy in practice: reflecting rather than advising	source-matched	reviewed
C02-016	Motivational Interviewing: developing discrepancy	source-matched	reviewed
C02-017	Motivational Interviewing: rolling with resistance	source-matched	reviewed
C02-018	Motivational Interviewing: adjusting to resistance	source-matched	reviewed
C02-019	Motivational Interviewing: supporting self-efficacy	source-matched	reviewed
C02-020	Change Talk categories (DARN)	source-matched	reviewed
C02-021	Motivational Interviewing: ambivalence and movement toward change	source-matched	reviewed
C02-022	Motivational Interviewing: facilitators and barriers	source-matched	reviewed
C02-023	CBT: definition and delivery formats	source-matched	reviewed
C02-024	CBT: cognitive model of events	source-matched	reviewed
C02-025	CBT: thought processes and control over feelings	source-matched	reviewed
C02-026	CBT: thought-process categories	source-matched	reviewed
C02-027	CBT: mechanism of change	source-matched	reviewed
C02-028	CBT: desired results and goal-setting	source-matched	reviewed
C02-029	CBT: behavior change through new habits	source-matched	reviewed
C02-030	CBT applied to tobacco treatment	source-matched	reviewed
C02-031	CBT and special populations	source-matched	reviewed
C02-032	CBT effectiveness in combination with other therapy	source-matched	reviewed
C02-033	Tailored treatment flexibility	source-matched	reviewed
C02-034	Tailored treatment example	source-matched	reviewed
C02-035	Establishing a nonjudgmental environment	skill	reviewed
C02-036	Active listening and empathy as core skills	skill	reviewed
C02-037	Evidence-based brief intervention method	skill	reviewed
C02-038	Models of behavior change and motivation measures	skill	reviewed
C02-039	Building motivation without pushing	skill	reviewed
C02-040	Competence in at least one empirically supported modality	skill	reviewed
C02-041	Motivational Interviewing: reflective listening, second scenario	source-matched	reviewed
C02-042	Client-Centered Therapy: autonomy, second scenario	source-matched	reviewed
C02-046	Client-Centered Therapy: tobacco use as a chronic disease	source-matched	reviewed
C02-047	Combined counseling and pharmacotherapy: contact-time threshold applied	source-matched	reviewed
C02-048	Motivational Interviewing: avoiding confrontation, direction, and warning	source-matched	reviewed
C02-049	Motivational Interviewing: probing facilitators and barriers together	source-matched	reviewed
C02-050	Clinically sound motivation-building versus pressure tactics	skill	reviewed
C02-051	Change Talk (DARN): classifying a client statement	source-matched	reviewed
C02-052	Establishing a confidential environment: physical privacy	skill	reviewed
C02-053	CBT combined with an existing Motivational Interviewing practice	source-matched	reviewed
C02-054	Brief intervention under real time constraints	skill	reviewed

Competency 3 · Assessment Interview

11% of the exam · 36 questions · 31 carry a source-matched claim

Show all 36

ID	Topic	Claim	Review
C03-001	Tobacco use history - current use window	source-matched	reviewed
C03-002	Pack-year arithmetic - two smoking periods	source-matched	reviewed
C03-003	Pack-year arithmetic - single smoking period	source-matched	reviewed
C03-004	Pack-year metric limited to smoking history	source-matched	reviewed
C03-005	Age of tobacco use initiation	source-matched	reviewed
C03-006	Tobacco use history - documenting past abstinence	source-matched	reviewed
C03-007	Tobacco use history - prior treatment experience	source-matched	reviewed
C03-008	Transtheoretical Model - stage order	source-matched	reviewed
C03-009	Transtheoretical Model - added Relapse stage	source-matched	reviewed
C03-010	Stage of change vignette - Preparation	source-matched	reviewed
C03-011	Motivational readiness - ladder scale range	source-matched	reviewed
C03-013	Fagerstrom Test - standard version population	source-matched	reviewed
C03-014	Fagerstrom Test - smokeless-specific version	source-matched	reviewed
C03-015	Fagerstrom Test - e-cigarette-specific version	source-matched	reviewed
C03-016	Heaviness of Smoking Index - components	source-matched	reviewed
C03-017	HONC - construct and population	source-matched	reviewed
C03-018	Penn State indexes: what they are for	source-matched	reviewed
C03-019	Choosing a dependence measure - adolescent vaping vignette	source-matched	reviewed
C03-020	Social support - exposure as relapse risk factor	source-matched	reviewed
C03-021	Additional assessment factors - access, insurance, culture	source-matched	reviewed
C03-022	Cultural factors vignette	skill	reviewed
C03-023	Drawing out what will help and what will get in the way	skill	reviewed
C03-024	Screening for co-occurring conditions at intake	skill	reviewed
C03-025	Focused medical or mental health assessment - conditions to identify	source-matched	reviewed
C03-026	Red flags requiring assess, screen, refer	source-matched	reviewed
C03-027	Red flag vignette - emotional instability during intake	source-matched	reviewed
C03-028	Consulting and referring before treatment planning	skill	reviewed
C03-029	Biochemical testing - matching the test to the product	source-matched	reviewed
C03-030	Cotinine half-life reasoning	source-matched	reviewed
C03-031	Biochemical/physiologic testing - purpose of spirometry	source-matched	reviewed
C03-032	CO reading confounders	source-matched	reviewed
C03-033	CO cut-off value associated with abstinence	source-matched	reviewed
C03-034	Non-tobacco nicotine products in the use history	source-matched	reviewed
C03-035	Quantity of each product as a distinct history element	source-matched	reviewed
C03-036	Treatment preferences as an intake-interview element	skill	reviewed
C03-037	Social support's dual role -- facilitator or barrier	source-matched	reviewed

Competency 4 · Treatment Planning

13% of the exam · 40 questions · 32 carry a source-matched claim

Show all 40

ID	Topic	Claim	Review
C04-002	Individualized treatment planning	source-matched	reviewed
C04-003	Evidence-based treatment components	source-matched	reviewed
C04-004	Behavioral counseling when medication is contraindicated	source-matched	reviewed
C04-005	Treatment-seeking behavior	source-matched	reviewed
C04-007	Treatment delivery settings	source-matched	reviewed
C04-008	Alternative and emerging treatment modalities	source-matched	reviewed
C04-009	Treatment intensity and outcomes	source-matched	reviewed
C04-010	Treatment intensity and outcomes	source-matched	reviewed
C04-011	Relapse-risk anticipation	source-matched	reviewed
C04-012	5 A's framework	source-matched	reviewed
C04-013	5 A's framework — practice gap	source-matched	reviewed
C04-014	5 A's framework — follow-up gap	source-matched	reviewed
C04-015	5 R's framework	source-matched	reviewed
C04-016	5 R's framework — indication for use	source-matched	reviewed
C04-017	5 R's framework — component identification	source-matched	reviewed
C04-018	Trigger and cue management	source-matched	reviewed
C04-019	Adjusting the plan over time	source-matched	reviewed
C04-020	Collaborative plan adjustment	source-matched	reviewed
C04-021	Social support and abstinence	source-matched	reviewed
C04-022	Environmental barriers	source-matched	reviewed
C04-023	Post-quit ongoing counseling	source-matched	reviewed
C04-024	Post-quit ongoing counseling	source-matched	reviewed
C04-025	Reduce-to-quit approaches	source-matched	reviewed
C04-026	Product switching and dual use	source-matched	reviewed
C04-027	Co-occurring mental illness/substance use	source-matched	reviewed
C04-028	Coordinating with other providers	source-matched	reviewed
C04-029	Measurable treatment objectives	skill	reviewed
C04-030	Measurable treatment objectives	skill	reviewed
C04-032	Individualizing the plan to assessment factors	skill	reviewed
C04-034	Assessment findings shaping the plan	skill	reviewed
C04-035	Collaborative, evidence-based plan development	skill	reviewed
C04-036	Collaborative, evidence-based plan development	skill	reviewed
C04-038	Follow-up planning	skill	reviewed
C04-040	Referrals to other providers	skill	reviewed
C04-041	Emerging evidence for e-cigarettes in cessation	source-matched	reviewed
C04-042	Group counseling among treatment settings with good evidence	source-matched	reviewed
C04-043	Co-occurring conditions -- assumption that clients don't want to quit	source-matched	reviewed
C04-044	Tobacco abstinence benefiting co-occurring conditions	source-matched	reviewed
C04-045	5 A's -- recognizing the Assess step	source-matched	reviewed
C04-046	5 R's -- recognizing the Relevance component	source-matched	reviewed

Competency 5 · Pharmacotherapy

15% of the exam · 53 questions · 49 carry a source-matched claim

Show all 53

ID	Topic	Claim	Review
C05-001	The three drug classes approved for quitting	source-matched	reviewed
C05-002	Psychotropic class trade names	source-matched	reviewed
C05-003	First-line medication definition	source-matched	reviewed
C05-004	OTC forms of NRT	source-matched	reviewed
C05-005	Prescription-only forms of NRT	source-matched	reviewed
C05-006	Nicotine delivery trajectory vs cigarettes	source-matched	reviewed
C05-007	Nicotine nasal spray delivery trajectory	source-matched	reviewed
C05-008	Nicotine patch wear time	source-matched	reviewed
C05-009	Second-line cessation agents identified	source-matched	reviewed
C05-010	Clonidine drug class	source-matched	reviewed
C05-011	Nortriptyline drug class	source-matched	reviewed
C05-012	FDA approval status of second-line agents	source-matched	reviewed
C05-013	Cytisine regulatory status	source-matched	reviewed
C05-014	Cytisine mechanism of action	source-matched	reviewed
C05-015	Basis for NRT starting dose	source-matched	reviewed
C05-016	Gum/lozenge starting dose, high exposure	source-matched	reviewed
C05-017	Gum/lozenge starting dose, lower exposure	source-matched	reviewed
C05-018	Acidic beverage timing with oral NRT	source-matched	reviewed
C05-019	Individualized NRT dosing	source-matched	reviewed
C05-020	NRT effect on quit probability	source-matched	reviewed
C05-021	Combination NRT for breakthrough cravings	source-matched	reviewed
C05-022	Overall safety of cessation medications vs tobacco	source-matched	reviewed
C05-023	Nicotine patch side effects	source-matched	reviewed
C05-024	Nicotine gum and lozenge side effects	source-matched	reviewed
C05-025	Nicotine gum caution in jaw disorders	source-matched	reviewed
C05-026	Nicotine nasal spray side effects	source-matched	reviewed
C05-027	Nicotine inhaler side effects and lung disease caution	source-matched	reviewed
C05-028	Smoking while wearing the nicotine patch	source-matched	reviewed
C05-029	Bupropion mechanism of action	source-matched	reviewed
C05-030	Bupropion contraindication in seizure history	source-matched	reviewed
C05-031	Bupropion caution in hepatic impairment vs varenicline's renal caution	source-matched	reviewed
C05-032	Bupropion side effects	source-matched	reviewed
C05-033	Bupropion drug interaction potential	source-matched	reviewed
C05-034	Varenicline mechanism of action	source-matched	reviewed
C05-035	Varenicline dose titration rationale	source-matched	reviewed
C05-036	Varenicline side effects	source-matched	reviewed
C05-037	Varenicline renal clearance and dose adjustment	source-matched	reviewed
C05-038	Start timing of varenicline and bupropion	source-matched	reviewed
C05-039	Neuropsychiatric warning history for varenicline and bupropion	source-matched	reviewed
C05-040	Monitoring for behavioral changes on varenicline/bupropion	source-matched	reviewed
C05-041	Serious symptoms requiring medication discontinuation and referral	source-matched	reviewed
C05-042	Duration of nicotine withdrawal symptoms	source-matched	reviewed
C05-043	Onset and peak timing of nicotine withdrawal symptoms	source-matched	reviewed
C05-044	Extending course of treatment for long-term abstinence	source-matched	reviewed
C05-045	Tobacco smoke and drug metabolism after quitting	source-matched	reviewed
C05-046	Pregnancy and lactation considerations for cessation medications	source-matched	reviewed
C05-047	Communicating withdrawal symptom expectations	skill	reviewed
C05-048	Collaborating with other healthcare providers	skill	reviewed
C05-049	Using recognized evidence reviews for alternative therapies	skill	reviewed
C05-050	Explaining why the two together work best	skill	reviewed
C05-051	Choosing a first-line agent with a seizure history and normal renal function	source-matched	reviewed
C05-052	Matching second-line agent class to a client's comorbidity	source-matched	reviewed
C05-053	Combination therapy choice with a seizure contraindication and heavy dependence	source-matched	reviewed

Competency 6 · Relapse Prevention

8% of the exam · 24 questions · 21 carry a source-matched claim

Show all 24

ID	Topic	Claim	Review
C06-001	Lapse vs. relapse definition	source-matched	reviewed
C06-003	Lapse-to-relapse progression risk	source-matched	reviewed
C06-005	Why quitting is rarely a single attempt	source-matched	reviewed
C06-006	Non-judgmental approach to interim use	source-matched	reviewed
C06-007	Risk factor: nicotine dependence severity	source-matched	reviewed
C06-008	Risk factor: psychiatric co-morbidity	source-matched	reviewed
C06-009	Risk factor: substance use	source-matched	reviewed
C06-010	Risk factor: exposure to other tobacco users	source-matched	reviewed
C06-011	Risk factor: easy access to tobacco	source-matched	reviewed
C06-012	Risk factor: high stress	source-matched	reviewed
C06-013	Risk factor: post-cessation weight gain	source-matched	reviewed
C06-014	Predictors versus consequences of relapse	source-matched	reviewed
C06-017	Trigger identification and self-efficacy	source-matched	reviewed
C06-019	Relapse timing window	source-matched	reviewed
C06-020	Treatment plan intensification	source-matched	reviewed
C06-021	Treatment plan intensification	source-matched	reviewed
C06-022	Follow-up and early recognition	source-matched	reviewed
C06-023	Collaborative coping-strategy development	source-matched	reviewed
C06-025	Aftercare planning	skill	reviewed
C06-026	Ongoing support resources	source-matched	reviewed
C06-027	Referral for additional resources	skill	reviewed
C06-028	Reviewing prior quit attempts	source-matched	reviewed
C06-029	Framing quitting as a process, not pass/fail	source-matched	reviewed
C06-030	Treatment strategy after a lapse or relapse	skill	reviewed

Competency 7 · Diversity and Specific Health Issues

7% of the exam · 30 questions · 24 carry a source-matched claim

Show all 30

ID	Topic	Claim	Review
C07-001	Culture and tobacco use patterns	source-matched	reviewed
C07-002	Tobacco industry marketing as a treatment barrier	source-matched	reviewed
C07-003	Pregnancy as a treatment opportunity	source-matched	reviewed
C07-004	Coordinating pharmacotherapy with perinatal providers	source-matched	reviewed
C07-005	Infant benefit of prenatal cessation: low birth weight	source-matched	reviewed
C07-006	Infant benefit of prenatal cessation: SIDS	source-matched	reviewed
C07-007	Infant benefit of prenatal cessation: cleft deformities	source-matched	reviewed
C07-008	Longer-term benefit of prenatal cessation: ADHD	source-matched	reviewed
C07-009	Prevalence of smoking among people with mental illness	source-matched	reviewed
C07-010	Desire to quit among people with mental illness	source-matched	reviewed
C07-011	Collaboration with mental health providers	source-matched	reviewed
C07-012	Treatment intensity for mental illness and other addictions	source-matched	reviewed
C07-013	Misperception that quitting harms substance use recovery	source-matched	reviewed
C07-014	Building concurrent cessation into co-occurring program design	source-matched	reviewed
C07-015	Continued smoking after a cancer diagnosis	source-matched	reviewed
C07-016	Lung cancer screening as a cessation opportunity	source-matched	reviewed
C07-017	Informing clients about provider collaboration	source-matched	reviewed
C07-018	Recognizing red flags and emergent referral	source-matched	reviewed
C07-019	Non-combustible products are not harmless	source-matched	reviewed
C07-020	Evidence-based treatment effectiveness across product types	source-matched	reviewed
C07-021	Secondhand and thirdhand smoke exposure risk	source-matched	reviewed
C07-022	Cessation reduces exposure risk for others	source-matched	reviewed
C07-023	Vaping aerosol exposure risk to bystanders	source-matched	reviewed
C07-024	Smoke-free policy as a treatment lever	source-matched	reviewed
C07-025	Population-specific treatment indications	skill	reviewed
C07-026	Treatment recommendations and referrals for co-morbid conditions	skill	reviewed
C07-027	Recommendations for non-cigarette tobacco and nicotine forms	skill	reviewed
C07-028	Advising a household exposed to secondhand smoke	skill	reviewed
C07-029	Hospitalized patients as a treatment opportunity	skill	reviewed
C07-030	Distinct indications for young adults versus elderly clients	skill	reviewed

Competency 8 · Documentation and Evaluation

5% of the exam · 20 questions · 17 carry a source-matched claim

Show all 20

ID	Topic	Claim	Review
C08-001	Purpose of quantifiable documentation	source-matched	reviewed
C08-002	7-day point prevalence abstinence definition	source-matched	reviewed
C08-003	24-hour vs 7-day point prevalence discrimination	source-matched	reviewed
C08-004	Date-last-used as basis for longer-term abstinence	source-matched	reviewed
C08-005	Long-term outcome intervals	source-matched	reviewed
C08-006	Difficulty of collecting long-term outcome data	source-matched	reviewed
C08-007	Denominator and numerator for quit-rate calculation	source-matched	reviewed
C08-008	Intent-to-treat analysis definition	source-matched	reviewed
C08-009	Applied intent-to-treat calculation	source-matched	reviewed
C08-010	Applied program-completer calculation	source-matched	reviewed
C08-011	Why intent-to-treat and completer rates diverge	source-matched	reviewed
C08-012	Multi-step calculation with denominator selection	source-matched	reviewed
C08-013	Treatment of missing follow-ups under intent-to-treat	source-matched	reviewed
C08-014	Point prevalence vs continuous abstinence discrimination	source-matched	reviewed
C08-015	Purpose of systematic program evaluation	source-matched	reviewed
C08-016	EHR-driven automatic referral	source-matched	reviewed
C08-017	Using the record to find and follow tobacco users	source-matched	reviewed
C08-018	Accurate records and setting-appropriate coding	skill	reviewed
C08-019	Keeping track of who came back	skill	reviewed
C08-020	Standardized outcome measurement: individual vs program level	skill	reviewed

Competency 9 · Professional Resources

4% of the exam · 18 questions · 13 carry a source-matched claim

Show all 18

ID	Topic	Claim	Review
C09-001	Quitline as a stand-alone cessation approach	source-matched	reviewed
C09-002	Quitline tailored programming for pregnant clients	source-matched	reviewed
C09-003	Named high-risk groups for tailored quitline programs	source-matched	reviewed
C09-004	Referral pathway for a co-occurring psychiatric concern	skill	reviewed
C09-005	Minimum breadth of a TTS's community referral list	skill	reviewed
C09-006	Maintaining abstinence after active treatment ends	skill	reviewed
C09-007	Smokefree.gov as a named community resource	source-matched	reviewed
C09-008	Surgeon General Reports as a reliable evidence source	source-matched	reviewed
C09-009	USPSTF and professional-association guidelines as reliable evidence	source-matched	reviewed
C09-010	AHRQ as a reliable evidence source	source-matched	reviewed
C09-011	PubMed vs. an anecdotal colleague report	source-matched	reviewed
C09-012	Tobacco-industry-funded material and misinformation risk	source-matched	reviewed
C09-013	Using professional societies and newsletters for ongoing knowledge	skill	reviewed
C09-014	Resolving conflicting studies by funding source and review status	source-matched	reviewed
C09-015	Correct ICD-10/CPT coding for billing tobacco treatment	source-matched	reviewed
C09-016	Documenting counseling time for both billing and evaluation	source-matched	reviewed
C09-017	What reimbursement documentation requires	skill	reviewed
C09-018	Audit finding tied to missing time documentation	source-matched	reviewed

Competency 10 · Ethics

4% of the exam · 18 questions · 18 carry a source-matched claim

Show all 18

ID	Topic	Claim	Review
C10-001	Fair and equitable treatment across identities	source-matched	reviewed
C10-002	Cultural respect versus a specialist's personal disapproval	source-matched	reviewed
C10-003	Consent and confidentiality as the floor, not the ceiling	source-matched	reviewed
C10-004	Confidentiality when a family member requests information	source-matched	reviewed
C10-005	Providing complete information for the client's own decision	source-matched	reviewed
C10-006	Full disclosure without directive pressure toward one option	source-matched	reviewed
C10-007	Accurately representing one's own training and credentials	source-matched	reviewed
C10-008	Referring a case that exceeds current training	source-matched	reviewed
C10-009	Truthful claims about treatment effectiveness	source-matched	reviewed
C10-010	Employer pressure to overstate program benefits	source-matched	reviewed
C10-011	Recognizing an activity that is a conflict of interest	source-matched	reviewed
C10-012	A pharmaceutical representative's incentive to favor one product	source-matched	reviewed
C10-013	Ongoing obligation to maintain competence through training	source-matched	reviewed
C10-014	Choosing between familiar methods and updated training	source-matched	reviewed
C10-015	Tobacco-free status requirement, including e-cigarettes	source-matched	reviewed
C10-016	Required sequence after a provider resumes tobacco use	source-matched	reviewed
C10-017	HIPAA's privacy rule and which entities it covers	source-matched	reviewed
C10-018	Distinguishing protected health information from de-identified data in a group setting	source-matched	reviewed

Competency 11 · Professional Development

3% of the exam · 10 questions · 5 carry a source-matched claim

Show all 10

ID	Topic	Claim	Review
C11-001	Certification vs. certificate distinction	source-matched	reviewed
C11-003	Purpose of accrediting TTS training programs	source-matched	reviewed
C11-005	Timeframe for applying ATTUD Core Competencies	source-matched	reviewed
C11-008	Experienced specialist resisting further training	source-matched	reviewed
C11-009	Recognized formal dissemination channels	source-matched	reviewed
C11-011	Dual obligation when license and certification both apply	skill	reviewed
C11-012	Formal literature review vs. informal updates	skill	reviewed
C11-013	Translating research findings into practice implications	skill	reviewed
C11-014	Proactive vs. reactive knowledge sharing	skill	reviewed
C11-015	Standards obligation for certification without a separate license	skill	reviewed

The wider bibliography

95 works cited by the source guide across all 11 competencies, de-duplicated and listed alphabetically.

1. Agboola, S., McNeill, A., Coleman, T., & Leonardi Bee, J. (2010). A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction, 105(8), 1362-1380.
2. American Lung Association. Billing Guide for Tobacco Screening and Cessation. April 2021.
3. Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Evins, A. E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet, 387(10037), 2507-2520.
4. Apollonio, D., Philipps, R., Bero, L. (2016). Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database of Systematic Reviews, Issue 11: CD010274.
5. Association for the Treatment of Tobacco Use and Dependence & NAADAC, the Association for Addiction Professionals (date unknown). Tobacco Treatment Provider Code of Ethics [White paper].
6. Baker, T. B., Piper, M. E., Stein, J. H., & et al. (2016). Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: A randomized clinical trial. JAMA, 315(4), 371-379.
7. Benowitz, N. L. (2009). Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol, 49, 57-71.
8. Boudreaux, E.D., Sullivan, A., Abar, B., Bernstein, S.L., Ginde, A.A., & Camargo, C.A. (2012) Motivation rulers for smoking cessation: a prospective observational examination of construct and predictive validity. Addiction Science & Clinical Practice, 7(1), 8.
9. Boyle, R., Solberg, L., Fiore, M. (2014). Use of electronic health records to support smoking cessation. Cochrane Database of Systematic Reviews, Issue 12: CD008743.
10. Centers for Disease Control and Prevention (2021). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
11. Centers for Disease Control and Prevention. (2014). Best Practices for Comprehensive Tobacco Control Programs. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
12. Centers for Disease Control and Prevention. Identifying and Treating Patients Who Use Tobacco: Action Steps for Clinicians. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2016.
13. Claire, R., Chamberlain, C., Davey, M., Cooper, S.E., Berlin, I., Leonardi-Bee, J., Coleman, T. (2020). Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews, Issue 3.
14. Cropsey, K.L., Trent, L.R., Clark, C.B., Stevens, E.N., Lahti, A.C., & Hendricks. P.S. (2014). How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine Tob Res, 16(10), 1348-1355.
15. Deyton, L., Sharfstein, J., & Hamburg, M. (2010). Tobacco Product Regulation — A Public Health Approach. New England Journal of Medicine, 362(19), 1753-1756.
16. Drope, J., Liber, A.C., Cahn, Z., Stoklosa, M., Kennedy, R., Douglas, C.E., Henson, R., and Drope, J. (2018). Who's still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA: A Cancer Journal for Clinicians, 68: 106-115.
17. Ebbert, J.O., Elrashidi, M.Y., Stead, L.F. (2015). Interventions for smokeless tobacco use cessation. Cochrane Database of Systematic Reviews, Issue 10: CD004306.
18. Eriksen M, Mackay J, Schluger N, Islami F, Drope J (2015). The Tobacco Atlas: Fifth Edition. American Cancer Society.
19. Ferguson, S. G., Gitchell, J. G., & Shiffman, S. (2012). Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction, 107(7), 1349-1353.
20. Fiore MC, Jaen CR, Baker TB, et. al. (2008). Treating Tobacco Use and Dependence: 2008. Update. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
21. Fiore, M. C., Jaen, C. R., Baker, T. B., & et al. (2008). Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
22. Fiore, M. C., Jaen, C. R., Baker, T. B., & et al. (2008). Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: U.S. Department of Health and Human Services.
23. Fiore, M.C. Jaen, C.R., Baker, T.B., et al. (2008). Treating tobacco use and dependence: 2008 Update. Rockville, MD: U.S. Department of Health and Human Services.
24. Fiore, M.C., Jean, C.R., Baker, T.B., et al. (2008). Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: U.S. Department of Health and Human Services.
25. Foulds, J., Veldheer, S., Yingst, J., Hrabovsky, S., Wilson, S.J., et al. (2015). Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res. Feb;17(2):186-92.
26. Fowler, C. D., Gipson, C. D., Kleykamp, B. A., Rupprecht, L. E., Harrell, P. T., Rees, V. W., . . ., the Basic Science Network (BSN) of the Society for Research on Nicotine and Tobacco (SRNT). (2017). Basic Science and Public Policy: Informed Regulation for Nicotine and Tobacco Products. Nicotine & Tobacco Research, 20(7), 789-799.
27. Fox, B.J. (2005). Framing tobacco control efforts within an ethical context. Tobacco Control 14: ii38-ii44.
28. Frazer, K., Callinan, J.E., McHugh, J., van Baarsel, S., Clarke, A., Doherty, K., Kelleher, C. (2016). Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database of Systematic Reviews, Issue 2: CD005992.
29. García-Rodríguez, O., Secades-Villa, R., Flórez-Salamanca, L., Okuda, M., Liu, S.-M., & Blanco, C. (2013). Probability and predictors of relapse to smoking: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence, 132(3), 479-485.
30. Gourlay, S.G., Stead, L.F., Benowitz, N. (2004). Clonidine for smoking cessation. Cochrane Database of Systematic Reviews, Issue 3: CD000058.
31. Gupta, S. K. (2011). Intention-to-treat concept: A review. Perspectives in clinical research, 2(3), 109–112.
32. Hartmann-Boyce, J, Theodoulou, A., Farley, A., Hajek, P., Lycett, D., Jones, L.L., Kudlek, L., Heath, L., Hajizadeh, A., Schenkels, M., Aveyard, P. (2021). Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews, Issue 10: CD006219.
33. Hartmann-Boyce, J., Chepkin, S.C., Ye, W., Bullen, C., Lancaster, T. (2018). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews, Issue 5: CD000146.
34. Hartmann-Boyce, J., Livingstone-Banks, J., Ordóñez-Mena, J.M., Fanshawe, T.R., Lindson, N., Freeman, S.C., Sutton, A.J., Theodoulou, A., Aveyard, P. (2020). Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews Issue 12: CD013229.
35. Hartmann-Boyce, J., Livingstone-Banks, J., Ordóñez-Mena, J.M., Fanshawe, T.R., Lindson, N., Freeman, S.C., Sutton, A.J., Theodoulou, A., Aveyard, P. (2020). Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews, Issue 12: CD013299.
36. Hendershot, C.S., Witkiewitz, K., George, W.H., & Marlatt, G.A. (2011). Relapse prevention for addictive behaviors. Subst Abuse Treat Prev Policy, 6(1), 17.
37. Hollands, G.J., Naughton, F., Farley, A., Lindson, N., Aveyard P. (2019). Interventions to increase adherence to medications for tobacco dependence. Cochrane Database of Systematic Reviews, Issue 8: CD009164.
38. Hughes, J. (2007). Tobacco Treatment Specialists: A New Profession. Journal of Smoking Cessation, 2(S1), 2-7.
39. Hughes, J. R., & Callas, P. W. (2011). Is Delaying a Quit Attempt Associated With Less Success? Nicotine & Tobacco Research, 13(12), 1228–1232.
40. Hughes, J. R., Carpenter, M. J., & Naud, S. (2010). Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review. Nicotine Tob Res, 12(7), 756-762.
41. Hughes, J. R., Keely, J., & Naud, S. (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction, 99(1), 29-38.
42. Hughes, J. R., Stead, L. F., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2014). Antidepressants for smoking cessation. Cochrane Database Syst Rev(1), CD000031.
43. Hughes, J.R. (2008). An algorithm for choosing among smoking cessation treatments. Journal of Substance Abuse Treatment, 34, 426-432.
44. King BA; Pechacek TF, Mariolis P; Centers for Disease Control and Prevention. (2014). Best Practices for Comprehensive Tobacco Control Programs. Office on Smoking and Health, Centers for Disease Control and Prevention (U.S.).
45. Kozlowski, L., Porter, C., Orleans, C., Pope, M., & Heatherton, T. (1994). Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend, 34, 211 - 216.
46. Lancaster, T., Stead, L.F. (2017). Individual behavioral counseling for smoking cessation. Cochrane Database of Systematic Reviews Issue 3: CD001292.
47. Lancaster, T., Stead, L.F. (2017). Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, Issue 3: CD001292.
48. Leone, F.T., Evers-Casey, S., Mulholland, M.A., & Sachs, D.P.L. (2016). Integrating Tobacco Use Treatment Into Practice: Billing and Documentation. Chest, 149(2), 568-575.
49. Lin, S.C., Gathua, N., Thompson, C., Sripipatana, A., & Makaroff, L. (2022). Disparities in smoking prevalence and associations with mental health and substance use disorders in underserved communities across the United States. Cancer, 128(9), 1826–1831. https://doi.org/10.1002/cncr.34132.
50. Lindson-Hawley, N., Banting, M., West, R., et al. (2016). Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med, 164, 585-592.
51. Lindson-Hawley, N., Hartmann-Boyce, J., Fanshawe, T.R., Begh, R., Farley, A., Lancaster, T. (2016). Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews, Issue 10: CD005231.
52. Lindson, N., Pritchard, G., Hong, B., Fanshawe, T.R., Pipe, A., Papadakis, S. (2021). Strategies to improve smoking cessation rates in primary care. Cochrane Database of Systematic Reviews, Issue 9: CD011556.
53. Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. (2023). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, Issue 6: CD006103.
54. Livingstone-Banks, J., Norris, E., Hartmann-Boyce, J., West, R., Jarvis, M., Chubb, E., Hajek, P. (2019). Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews, Issue 10: CD003999.
55. Marbin, J., Balk, S.J., Gribben, V., et al., (2021). Health Disparities in Tobacco Use and Exposure: A Structural Competency Approach. Pediatrics, 147(1).
56. Marcano Belisario, J.S., Bruggeling, M.N., Gunn, L.H., Brusamento, S., Car, J. (2012). Interventions for recruiting smokers into cessation programmes. Cochrane Database of Systematic Reviews, Issue 12: CD009187.
57. Matkin, W., Ordóñez-Mena, J., Hartmann-Boyce, J. (2019) Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews, Issue 5: CD002850.
58. Matkin, W., Ordóñez-Mena, J., Hartmann-Boyce, J. (2019). Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews, Issue 5: CD002850.
59. Mazzone, P.J., Silvestri, G.A., Souter, L.H., Caverly, T.J., Kanne, J.P., Katki, H.A., Wiener, R.S. & Detterbeck, F.C. (2021). Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest, 160(5), e427–e494.
60. McDermott, M. S., Beard, E., Brose, L. S., West, R., & McEwen, A. (2013). Factors associated with differences in quit rates between "specialist" and "community" stop- smoking practitioners in the English stop-smoking services. Nicotine Tob Res, 15(7), 1239-1247.
61. Meernik, C., & Goldstein, A. O. (2015). A critical review of smoking, cessation, relapse and emerging research in pregnancy and post-partum. British medical bulletin, 114(1), 135–146.
62. Miller, W.R. & Rollnick, S. (2013). Motivational Interviewing: Helping People Change (3rd Ed.). New York, NY: The Guilford Press.
63. Moolchan, E.T., Fagan, P., Fernander, Velicer, W.F., Hayward, M.D., King, G., and Clayton, R.R. (2007). Addressing tobacco-related health disparities. Addiction, 102: 30- 42.
64. Naar, S. & Safren, S.A. (2017). Motivational Interviewing and CBT. New York, NY: The Guilford Press.
65. Piano, M.R., Benowitz, N.L., Fitzgerald, G.A., Corbridge, S., Heath, J., Hahn, E.,…Howard, G. (2010). Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation, 122(15), 1520-1544.
66. Riaz, M., Lewis, S., Naughton, F., & Ussher, M. (2018). Predictors of smoking cessation during pregnancy: a systematic review and meta-analysis. Addiction, 113(4), 610–622.
67. Rigotti, N.A., Clair, C., Munafò, M.R., Stead, L.F. (2012). Interventions for smoking cessation in hospitalised patients. Cochrane Database of Systematic Reviews, Issue 5: CD001837.
68. Sheffer, C. E., Al-Zalabani, A., Aubrey, A., Bader, R., Beltrez, C., Bennett, S., . . . Wendling, A. (2021). The Emerging Global Tobacco Treatment Workforce: Characteristics of Tobacco Treatment Specialists Trained in Council-Accredited Training Programs from 2017 to 2019. Int J Environ Res Public Health, 18(5).
69. Sheffer, C., Payne, T., Ostroff, J., Jolicoeur, D., Steinberg, M., Czabafy, S., . . . Perry, B. (2016). Increasing the Quality and Availability of Evidence-based Treatment for Tobacco Dependence through Unified Certification of Tobacco Treatment Specialists. Journal of Smoking Cessation, 11(4), 229-235.
70. Simmons, V. N., Piñeiro, B., Hooper, M. W., Gray, J. E., & Brandon, T. H. (2016). Tobacco- Related Health Disparities across the Cancer Care Continuum. Cancer Control, 23(4), 434- 441.
71. Song, F., Maskrey, V., Blyth, A., Brown, T. J., Barton, G. R., Aveyard, P., . . . Brandon, T. H. (2016). Differences in Longer-Term Smoking Abstinence After Treatment by Specialist or Nonspecialist Advisors: Secondary Analysis of Data From a Relapse Prevention Trial. Nicotine Tob Res, 18(5), 1061-1066.
72. Soulakova, J. N., Tang, C. Y., Leonardo, S. A., & Taliaferro, L. A. (2018). Motivational Benefits of Social Support and Behavioural Interventions for Smoking Cessation. Journal of smoking cessation, 13(4), 216–226.
73. Stead, L.F., Carroll, A.J., Lancaster, T. (2017). Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews, Issue 3: CD001007.
74. Stead, L.F., Koilpillai, P., Fanshawe, T.R., Lancaster, T. (2016). Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews, Issue 3: CD008286.
75. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Substance Abuse & Mental Health Data Archive. National Survey on Drug Use and Health, 2019.
76. Summary of the HIPAA Privacy Rule. (2013). Retrieved June 18, 2023 from https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html
77. Swanson, J.A., Lee, J.W., & Hopp, J.W. (1994). Caffeine and nicotine: A review of their joint use and possible interactive effects in tobacco withdrawal. Addictive Behaviors, 19(3), 229-256.
78. Taylor, G. M. J., Itani, T., Thomas, K. H., Rai, D., Jones, T., Windmeijer, F., . . . Taylor, A. E. (2020). Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders. Nicotine Tob Res, 22(1), 48-57.
79. Taylor, G.M.J., Dalili, M.N., Semwal, M., Civljak, M., Sheikh, A., Car, J. (2017). Internet- based interventions for smoking cessation. Cochrane Database of Systematic Reviews, Issue 9: CD007078.
80. Taylor, G.M.J., Lindson, N., Farley, A., Leinberger-Jabari, A., Sawyer, K., te Water Naudé, R., Theodoulou, A., King, N., Burke, C., Aveyard, P. (2021). Smoking cessation for improving mental health. Cochrane Database of Systematic Reviews, Issue 3: CD013522.
81. The National Center for Health Statistics (NCHS), the federal agency responsible for use of the International Statistical Classification of Diseases and Related Health Problems in the United States, 10th revision (ICD-10), Fiscal Year 2015. http://www.cdc.gov/nchs/icd/icd10cm.htm
82. Thomas, J., Ebbert, J., Patten, C., Dale, L., Bronars, C., & Schroeder, D. (2006). Measuring nicotine dependence among smokeless tobacco users. Addictive Behaviors, 31(9), 1511- 1521.
83. Twyman, L., Bonevski, B., Paul, C., & Bryant, J. (2014). Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open, 4(12), e006414.
84. U.S. Department of Health and Human Services. (2014). The Health Consequences of Smoking— 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
85. U.S. Department of Health and Human Services. (2014). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
86. U.S. Department of Health and Human Services. (2020). Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S.
87. U.S. Department of Health and Human Services. (2020). Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S.,
88. U.S. Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., Jr, Kubik, M., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C. W., & Wong, J. B. (2021). Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA, 325(3), 265–279.
89. U.S. Public Health Service. Office of the Surgeon General. (2012). Preventing tobacco use among youth and young adults; a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
90. Vinci, C. (2020). Cognitive Behavioral and Mindfulness-Based Interventions for Smoking Cessation: a Review of the Recent Literature. Current oncology reports, 22(6), 58.
91. Wheeler, K. C., Fletcher, K. E., Wellman, R. J., & Difranza, J. R. (2004). Screening adolescents for nicotine dependence: the Hooked On Nicotine Checklist. J Adolesc Health, 35(3), 225- 230.
92. White, A.R., Rampes, H., Liu, J.P., Stead, L.F., & Campbell, J. (2014). Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev(1), CD000009.
93. WHO report on the global tobacco epidemic 2021: addressing new and emerging
94. World Health Organization. (2017). WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies. Geneva: World Health Organization.
95. Wu, A.D., Lindson, N., Hartmann-Boyce, J., Wahedi, A., Hajizadeh, A., Theodoulou, A., Thomas, E.T., Lee, C., Aveyard, P. (2022). Smoking cessation for secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, Issue 8: CD014936.